About Technology Issues FAQ

Links

Official Page

Risk of Febrile Neutropenia among Patients with Intermediate-grade non-Hodgkin's Lymphoma Receiving CHOP Chemotherapy

Risk of Febrile Neutropenia among Patients with Intermediate-grade non-Hodgkin's Lymphoma Receiving CHOP Chemotherapy — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.